...
首页> 外文期刊>Artificial Organs >Human clinical fitting study of the DexAide right ventricular assist device.
【24h】

Human clinical fitting study of the DexAide right ventricular assist device.

机译:DexAide右心室辅助装置的人体临床拟合研究。

获取原文
获取原文并翻译 | 示例

摘要

The DexAide right ventricular assist device (RVAD) has been developed as an implantable RVAD. The purpose of this study was to determine the final design and optimal anatomical placement of the DexAide RVAD when implanted simultaneously with either of two commercially available left ventricular assist devices (LVADs) in patients. A mock-up DexAide RVAD was used to assess configuration with each of two types of commercially available LVADs at the time of LVAD implantation in three human clinical cases. The pump body of the DexAide RVAD was placed either in the preperitoneal space or in the right thoracic cavity. The DexAide RVAD placed into the right thoracic cavity is suitable for use with the Novacor or HeartMate II LVADs. The results of this study will guide the finalization of the inflow cannula and optimal placement of the DexAide RVAD for human clinical trials.
机译:DexAide右心室辅助设备(RVAD)已开发为可植入RVAD。这项研究的目的是确定与两种市售左心室辅助装置(LVAD)同时植入时,DexAide RVAD的最终设计和最佳解剖位置。在三例人类临床病例中,当LVAD植入时,模型DexAide RVAD用于评估两种类型的市售LVAD的构型。 DexAide RVAD的泵体放置在腹膜前腔或右胸腔中。将DexAide RVAD放置在右胸腔中,适用于Novacor或HeartMate II LVAD。这项研究的结果将指导流入套管的最终确定以及DexAide RVAD在人体临床试验中的最佳放置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号